Severe Acute Respiratory-Syndrome Treatment Market Poised for 15.8 % Growth, Set to Hit $9.57 Billion by 2029

How Is the Severe Acute Respiratory-Syndrome Treatment Market Projected to Grow, and What Is Its Market Size?
The severe acute respiratory syndrome (SARS) treatment market has experienced rapid growth in recent years. It will rise from $3.45 billion in 2024 to $3.97 billion in 2025, at a CAGR of 15.2%. The growth is attributed to global outbreak responses, antiviral drug development, vaccine progress, and public health preparedness efforts.

The severe acute respiratory-syndrome treatment market is anticipated to grow rapidly, reaching $7.15 billion by 2029, with a CAGR of 15.8%. This growth is driven by broad-spectrum antivirals, emerging therapeutics, vaccine advancements, and pandemic preparedness. Key trends include RNA-targeted therapies, the use of AI in drug discovery, global collaborations, and public health education.

What Are the Key Drivers Behind the Growth of the Severe Acute Respiratory-Syndrome Treatment Market?
The rising prevalence of respiratory diseases is expected to accelerate the growth of the severe acute respiratory syndrome treatment market. Respiratory diseases encompass conditions affecting the respiratory system, responsible for oxygen exchange between the body and the external environment. Treatments for severe acute respiratory syndrome help alleviate symptoms, prevent respiratory failure, reduce inflammation, and maintain oxygen levels. For instance, in November 2023, the National Asthma Council, an Australia-based non-profit organization focused on asthma care, reported 467 asthma-related deaths in 2022, including 299 females and 168 males, marking an increase from the 355 deaths recorded in 2021. Therefore, the growing incidence of respiratory diseases is propelling the expansion of the severe acute respiratory syndrome treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13027&type=smp

Who Are the Major Industry Players Fueling Severe Acute Respiratory-Syndrome Treatment Market Expansion?
Major companies operating in the severe acute respiratory-syndrome treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck And Co Inc., Novartis AG, Bristol Myers Squib company, GlaxoSmithKline PLC, AstraZeneca PLC, Sanofi SA, Eli Lilly And Company, Gilead Sciences Inc., Amgen Inc., Johnson And Johnson Private Limited, Moderna Inc., Regeneron Pharmaceuticals Inc., Hetero labs Ltd., Alexion Pharmaceuticals Inc., Cadila healthcare Ltd., Genentech Inc., Cipla Ltd., Biogen Inc., Vir Biotechnology Inc., Swedish Orphan Biovitrum AB, Dynavax Technologies Corporation, ViiV Healthcare Limited, Panacea Biotec Limited, CureVac N.V., CN Bio Innovations Ltd., Inovio Pharmaceuticals Inc., Chimerix Inc.

Which Key Developments Are Influencing the Severe Acute Respiratory-Syndrome Treatment Market?
Top companies in the severe acute respiratory syndrome treatment market are adopting cutting-edge techniques, such as multiplexed real-time PCR, to maintain their competitive position. Multiplexed real-time PCR is a molecular biology method that facilitates the amplification and simultaneous detection of multiple DNA or RNA targets in a single test. For instance, in July 2022, TransGen Biotech Co. Ltd., a Beijing-based molecular and cellular biology product manufacturer, launched the Trans-SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus Assay. This novel assay is a multiplexed real-time PCR test designed to detect and differentiate between severe acute respiratory syndrome COVID-19 2 (SARS-CoV-2), Influenza A, Influenza B, and respiratory syncytial virus (RSV) using a single specimen. This tool plays a crucial role in diagnosing and treating SARS, influenza, and RSV, aiding in appropriate treatment decisions and preventing disease transmission.

How Is the Segmentation of the Severe Acute Respiratory-Syndrome Treatment Market Defined?
The severe acute respiratory-syndrome treatment market covered in this report is segmented -

1) By Drug Class: Antibiotics, Antiviral, Corticosteroids, Monoclonal Antibodies, Other Drug Classes
2) By Route Of Administration: Oral, Intravenous
3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV), Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2)
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics
2) By Antiviral: Nucleoside Analogs, Protease Inhibitors
3) By Corticosteroids: Systemic Corticosteroids, Inhaled Corticosteroids
4) By Monoclonal Antibodies: Neutralizing Antibodies, Non-Neutralizing Antibodies
5) By Other Drug Classes: Immunomodulators, Supportive Medications

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/severe-acute-respiratory-syndrome-treatment-global-market-report

What Is the Leading Region in the Severe Acute Respiratory-Syndrome Treatment Market?
North America was the largest region in the severe acute respiratory syndrome treatment market in 2024. Western Europe is expected to be the fastest-growing region in the forecast period. The regions covered in severe acute respiratory syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Severe Acute Respiratory-Syndrome Treatment Global Market Report?

- Market Size Analysis: Analyze the Severe Acute Respiratory-Syndrome Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Severe Acute Respiratory-Syndrome Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Severe Acute Respiratory-Syndrome Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Severe Acute Respiratory-Syndrome Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13027

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.